The Global Ambulatory Infusion Center Market Growth Accelerated By Increasing Geriatric Population
![]() |
Ambulatory infusion centers market |
Ambulatory infusion centers provide convenient and cost-effective treatments to patients suffering from chronic diseases and disorders. These centers offer various therapies such as chemotherapy, pain management, antibiotic therapy, intravenous immunoglobulin, and others. Ambulatory infusion centers reduce the risk of hospital-acquired infections and provide comfortable treatment to patients. The global Ambulatory Infusion Center Market is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing geriatric
population is one of the major factors driving the growth of the ambulatory
infusion center market. As per the United Nations, the population aged 60 years
or above is expected to double from 12% to 22% between 2015 and 2050. The aging
population is more susceptible to chronic diseases such as cancer, diabetes,
respiratory diseases, cardiovascular diseases, and others necessitating
long-term IV treatment. According to estimates by the Centers for Disease
Control and Prevention (CDC), around 60-65% of all US adults suffer from at
least one chronic disease. The rising prevalence of chronic disorders has
increased the demand for ambulatory infusion services globally. This has
encouraged healthcare providers to invest in outpatient infusion services
catering to patient needs.
Segment Analysis
The global ambulatory infusion
center market is dominated by stand-alone infusion centers segment. Stand-alone
infusion centers are not attached to any hospitals and solely involved in
delivering outpatient infusion services. These centers provide convenient
options for patients as they can visit these centers as per their comfort
without hospital related formalities. Also, standalone centers offer a more
flexible schedule and privacy which driving their demand over hospital based
centers.
Key Takeaways
The Global
Ambulatory Infusion Center Market Size is expected to witness high
growth over the forecast period of 2023 to 2030. The market is anticipated to
grow at a CAGR of 6.7% during the forecast period. By 2030, the size of
ambulatory infusion center market is projected to reach US$ 118,084.69 Mn.
Regional analysis
North America region currently
dominates the ambulatory infusion center market owing to growing preference for
outpatient services. The United States accounts for the major share in the
North America ambulatory infusion center market. Growing popularity of
standalone infusion centers along with supportive reimbursement policies are
fueling the market growth in the region. Europe is also expected to witness
significant growth in the ambulatory infusion center market during the forecast
period.
Key players
Key players operating in the ambulatory infusion center
market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton
Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI
Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health
and Precision Healthcare. Option Care Health and PharmaScript collectively hold
largest market share in the global ambulatory infusion center market.
Get More Insights Here
https://www.newsstatix.com/ambulatory-infusion-center-market-share-size-forecast-outlook-2023-2030/
Comments
Post a Comment